^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Archer® FusionPlex® Lymphoma

Type:
Laboratory Developed Test
Related tests:

Details

Evidence
The Archer® FusionPlex® Lymphoma Kit is a targeted next generation sequencing assay to simultaneously detect and identify fusions, point mutations, and expression levels in 125 genes linked to lymphomas. Using Anchored Multiplex PCR (AMP™)-based enrichment, fusions can be identified even without prior knowledge of fusion partners or breakpoints.
Cancer:
Lymphoma
Gene:
AKT3 (V-akt murine thymoma viral oncogene homolog 3), ALK (Anaplastic lymphoma kinase), BRAF (B-raf proto-oncogene), CCND1 (Cyclin D1), CCND2 (Cyclin D2), CCND3 (Cyclin D3)
See More ...
Method:
Next-Generation Sequencing (NGS)